Your browser doesn't support javascript.
loading
Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge.
Nose, Taku; Funakoshi, Yohei; Suto, Hirotaka; Nagatani, Yoshiaki; Imamura, Yoshinori; Toyoda, Masanori; Kiyota, Naomi; Minami, Hironobu.
Affiliation
  • Nose T; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Funakoshi Y; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Suto H; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Nagatani Y; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Imamura Y; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Toyoda M; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Kiyota N; Department of Medicine, Division of Medical Oncology/Hematology, Kobe University, Hospital and Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  • Minami H; Cancer Center, Kobe University Hospital, Kobe, Hyogo 650-0017, Japan.
Mol Clin Oncol ; 16(5): 104, 2022 May.
Article de En | MEDLINE | ID: mdl-35463212
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Mol Clin Oncol Année: 2022 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Mol Clin Oncol Année: 2022 Type de document: Article Pays d'affiliation: Japon